Cargando…

How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing

BACKGROUND: Sampling and testing for SARS‐CoV‐2 is a widely recognized method for identifying patients with COVID‐19. However, there is limited research available on the stability of nucleic acids in viral storage solutions. METHODS: This paper investigates the components that provide better protect...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiuzhi, Huang, Letao, Wang, Xuchu, Ping, Ying, Yu, Pan, Liu, Weiwei, Xie, Yiyi, Tao, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561591/
https://www.ncbi.nlm.nih.gov/pubmed/37661301
http://dx.doi.org/10.1002/jcla.24956
_version_ 1785117956379770880
author Duan, Xiuzhi
Huang, Letao
Wang, Xuchu
Ping, Ying
Yu, Pan
Liu, Weiwei
Xie, Yiyi
Tao, Zhihua
author_facet Duan, Xiuzhi
Huang, Letao
Wang, Xuchu
Ping, Ying
Yu, Pan
Liu, Weiwei
Xie, Yiyi
Tao, Zhihua
author_sort Duan, Xiuzhi
collection PubMed
description BACKGROUND: Sampling and testing for SARS‐CoV‐2 is a widely recognized method for identifying patients with COVID‐19. However, there is limited research available on the stability of nucleic acids in viral storage solutions. METHODS: This paper investigates the components that provide better protection for virus and nucleic acid detection. The study utilized real‐time quantitative fluorescent PCR to detect SARS‐CoV‐2 and evaluate the preservation effect and stability of SARS‐CoV‐2 viral storage solution under various conditions, including different guanidinium salts, brands, and storage conditions. RESULTS: All brands of inactivated virus preservation solutions demonstrated effective preservation and stability. However, 0.5 mol/L guanidine hydrochloride and guanidine isothiocyanate solutions exhibited poor antiseptic effects. Additionally, refrigerated storage showed better preservation compared to room temperature storage. CONCLUSIONS: We recommend using inactivated virus collection solution to preserve and transport samples and testing preferably within 6 hours to reduce false negatives of NAT results.
format Online
Article
Text
id pubmed-10561591
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105615912023-10-10 How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing Duan, Xiuzhi Huang, Letao Wang, Xuchu Ping, Ying Yu, Pan Liu, Weiwei Xie, Yiyi Tao, Zhihua J Clin Lab Anal Research Articles BACKGROUND: Sampling and testing for SARS‐CoV‐2 is a widely recognized method for identifying patients with COVID‐19. However, there is limited research available on the stability of nucleic acids in viral storage solutions. METHODS: This paper investigates the components that provide better protection for virus and nucleic acid detection. The study utilized real‐time quantitative fluorescent PCR to detect SARS‐CoV‐2 and evaluate the preservation effect and stability of SARS‐CoV‐2 viral storage solution under various conditions, including different guanidinium salts, brands, and storage conditions. RESULTS: All brands of inactivated virus preservation solutions demonstrated effective preservation and stability. However, 0.5 mol/L guanidine hydrochloride and guanidine isothiocyanate solutions exhibited poor antiseptic effects. Additionally, refrigerated storage showed better preservation compared to room temperature storage. CONCLUSIONS: We recommend using inactivated virus collection solution to preserve and transport samples and testing preferably within 6 hours to reduce false negatives of NAT results. John Wiley and Sons Inc. 2023-09-03 /pmc/articles/PMC10561591/ /pubmed/37661301 http://dx.doi.org/10.1002/jcla.24956 Text en © 2023 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Duan, Xiuzhi
Huang, Letao
Wang, Xuchu
Ping, Ying
Yu, Pan
Liu, Weiwei
Xie, Yiyi
Tao, Zhihua
How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
title How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
title_full How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
title_fullStr How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
title_full_unstemmed How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
title_short How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
title_sort how to better select sars‐cov‐2 preservation solution of virus nucleic acid testing
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561591/
https://www.ncbi.nlm.nih.gov/pubmed/37661301
http://dx.doi.org/10.1002/jcla.24956
work_keys_str_mv AT duanxiuzhi howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT huangletao howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT wangxuchu howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT pingying howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT yupan howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT liuweiwei howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT xieyiyi howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting
AT taozhihua howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting